Last data update: Sep 16, 2021. (Total: 3468 publications since 2011)
|Query Trace: all>>Tracy L Dalton[CDC Author]|
| Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
Melisa Willby, Paige Chopra, Darrin Lemmer, Katherine Klein, Tracy L Dalton, David M Engelthaler, Peter Cegielski, James E Posey, and
Antimicrobial agents and chemotherapy 2020 Oct
Similar articles in PubMed DOI:10.1128/AAC.01663-20
| Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
Eleanor S Click, Ekaterina Kurbatova, Heather Alexander, Tracy L Dalton, Michael P Chen, James E Posey, Julia J Ershova, and Peter Cegielski
The Journal of infectious diseases 2020 Jan
Similar articles in PubMed DOI:10.1093/infdis/jiaa042
| Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Justin L Kandler, Alexandra D Mercante, Tracy L Dalton, Matthew N Ezewudo, Lauren S Cowan, Scott P Burns, Beverly Metchock, , Peter Cegielski, and James E Posey
Antimicrobial agents and chemotherapy 2018 Aug
Similar articles in PubMed DOI:10.1128/AAC.00974-18
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock, Angela M Starks, Delaina P Hooks, Lauren S Cowan, Bonnie B Plikaytis, and James E Posey
Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41
Similar articles in PubMed DOI:10.1128/AAC.01550-10